David V. Milligan, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 20,000 shares at $112.54 ($2.3M) on 2018-11-21, disclosed to the SEC on 2020-02-26.
Open-market sale of $2.3M MDGL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.